Lonza Netherlands (former PharmaCell) is a leading Contract Manufacturing Organization for Cellular Therapies in Europe.
With its 2 state-of-the-art full-scale GMP Cell Manufacturing Facilities in Maastricht and Geleen Lonza supports all phases of clinical development from process development and optimization as well as Phase I to Phase III clinical trial manufacturing. Next to clinical trial manufacturing Lonza is fully equipped to support and manufacture commercial cell therapy products. We currently produce 2 EMA approved ATMPs under long-term CMO contract.
Lonza’s Cell Therapy CMO services range from thorough transfer of technologies, QP release of products for the EU market, controlled temperature transportation to process development, including cell culture scale-up know-how and manufacturing of Advanced Therapeutic Medicinal Products.
Lonza’s international team consists of experts related to all quality aspects, manufacturing, engineering, process development and project management. Each department has a representative in a dedicated core team that is committed to your product manufacturing and becomes involved from the Technology Transfer onwards.